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Chronic inflammation is associated with normal and pathological ageing. Here we show that
chronic, progressive low-grade inflammation induced by knockout of the nfkb1 subunit of the
transcription factor NF-kB induces premature ageing in mice. We also show that these mice
have reduced regeneration in liver and gut. nfkb1ÿ /ÿ fibroblasts exhibit aggravated cell
senescence because of an enhanced autocrine and paracrine feedback through NF-kB, COX-2
and ROS, which stabilizes DNA damage. Preferential accumulation of telomere-dysfunctional
senescent cells in nfkb1ÿ /ÿ tissues is blocked by anti-inflammatory or antioxidant treatment
of mice, and this rescues tissue regenerative potential. Frequencies of senescent cells in liver
and intestinal crypts quantitatively predict mean and maximum lifespan in both short- and
long-lived mice cohorts. These data indicate that systemic chronic inflammation can accel-
erate ageing via ROS-mediated exacerbation of telomere dysfunction and cell senescence in
the absence of any other genetic or environmental factor.
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M
any age-related diseases and ageing itself are closely
associated with low-level chronic inflammation1,2. The
essential question whether chronic inflammation is
causal for the development of age-related disease and in normal
ageing has only very recently begun to be experimentally
addressed. Recent data show that inflammation may influence
systemic ageing via neuro-endocrine signalling3. On a tissue level,
inflammation might contribute to ageing in mouse skin4 and in
DNA damage-driven progeria mouse models5–7, suggesting
synergistic interactions between DNA damage responses
(DDRs) and inflammatory signals. However, the molecular and
cellular mechanisms of such interactions during ageing are still
not understood. Moreover, progerias are accompanied by severe
pathologies and the question how far such ageing models
resemble normal ageing remains unresolved8.
Telomere dysfunction inducing a persistent DDR is a major
cause of cellular senescence9. Severe telomere dysfunction is
induced by telomere shortening in late-generation telomerase
(tercÿ /ÿ ) knockout mice, where it compromises the function of
tissue-specific stem and progenitor cells, limits tissue regenerative
capacity and accelerates ageing10. However, telomere shortening
is just one mechanism to ‘uncap’ telomeres. Senescent cells
harbouring dysfunctional telomeres, which are recognized by
persistent telomere-associated DNA damage foci (TAF),
accumulate even in tissues of ageing mice with long telomeres,
suggesting that telomere dysfunction may contribute to age-
related decline in tissue function and regeneration during normal
ageing of mice11. Senescent cells activate hyper-production of
reactive oxygen species (ROS)12 and secrete bioactive, frequently
pro-inflammatory peptides (the so-called senescence-associated
secretory phenotype (SASP) or senescent-messaging
secretome)13–16. In senescent fibroblasts and in oncogene-
induced senescence, the SASP is closely controlled by signalling
through NF-kB16,17. Both senescence-associated ROS12 and
NF-kB-driven pro-inflammatory cytokines, especially IL-6 and
IL-8 (refs 13,14), contribute to positive feedback loops that
stabilize oncogene- or stress-induced senescence. In a specific
progeria mouse model, targeted ablation of senescent cells has
been sufficient to delay age-associated degenerative loss of
function in multiple tissues18. However, it is still unknown how
cell senescence might contribute to organism ageing.
We hypothesize that chronic low-grade inflammation might
enhance telomere dysfunction by increasing ROS-mediated DNA
damage and thus accelerate accumulation of senescent cells,
initiating a ‘circulus vitiosus’ in which cell senescence aggravates
chronic inflammation, limits tissue regeneration and accelerates
ageing.
To test this hypothesis, we utilized a mouse model of chronic
low-level inflammation, the nfkb1ÿ /ÿ mouse that lacks expres-
sion of the p105 and p50 NF-kB proteins. NF-kB is the cardinal
transcriptional regulator of inflammation-related genes including
pro-inflammatory interleukins, chemokines, cytokines, adhesion
molecules and others, and is itself activated by pro-inflammatory,
stress and cell senescence signals19. NF-kB controls inflammatory
gene expression through the activities of its five-subunit
components (RelA, RelB, c-Rel, p105/p50 and p100/p52), which
operate as homo- or heterodimers. The classic pro-inflammatory
NF-kB is the RelA:p50 heterodimer with RelA being required
for stimulation of target gene transcription. By contrast the
homodimer (p50:p50) is an active repressor of pro-inflammatory
gene transcription20. This repressive function is at least in part
attributed to the absence of a transactivation domain in p50 and
the ability of p50:p50 to recruit histone deactylase 1 (HDAC1) to
a subset of kB motifs20,21. The p50:p50:HDAC1 competes with
RelA-containing dimers for kB motifs and actively represses
transcription by deacetylation of histones. As a consequence
nfkb1ÿ /ÿ mice, which are unable to form p50:p50 but can still
generate RelA-containing NF-kB dimers, show enhanced
responses to inflammatory stimuli21,22 and are thought to have
a low-level elevated inflammatory phenotype20.
Our results show that chronic inflammation aggravates
telomere dysfunction and cell senescence, decreases regenerative
potential in multiple tissues and accelerates ageing of mice. Anti-
inflammatory or antioxidant treatment, specifically COX-2
inhibition, rescued telomere dysfunction, cell senescence and
tissue regenerative potential, indicating that chronic inflamma-
tion may accelerate ageing at least partially in a cell-autonomous
manner via COX-2-dependent hyper-production of ROS.
Results
Progressive chronic inflammation in nfkb1ÿ /ÿ mice. As
nfkb1ÿ /ÿ mice showed aggravated responses to pro-inflamma-
tory stimuli20,21, we tested whether these mice would display
evidence of sterile, chronic inflammation without any external
stimuli. This was in fact the case: nfkb1ÿ /ÿ mice showed
progressive splenomegaly, increasing plasma concentrations of
the major pro-inflammatory cytokine IL-6 and increasing
infiltration of CD3þ immune cells in the liver and other
organs (Table 1 and Fig. 1a–d). While levels of these
inflammatory markers were mostly inconspicuous at a young
age (12–18 weeks), they increased in 36-week-old nfkb1ÿ /ÿ mice
to levels similar to those found in 132-week-old wild-type (wt)
controls (Table 1 and Fig. 1a). Detailed analysis of the spleen
showed enlargement of both total white pulp and of the B cell-
containing germinal centres (Fig. 1b), indicating a humoral
immune response. Infiltration of CD3þ immune cells into
multiple tissues including lung, kidney and liver was increased in
nfkb1ÿ /ÿ mice (Fig. 1c). Kinetic analysis of the liver showed
progressive infiltration of CD3þ cells with age (Fig. 1d), which
could be suppressed by treatment with the anti-inflammatory
cyclooxygenase inhibitor ibuprofen (Fig. 1e) or the antioxidant
butylated hydroxyanisole (BHA; Fig. 1f) and was accompanied by
progressive fibrosis (Fig. 1g). Out of 78 NF-kB target genes,
43 were upregulated in 36-week-old nfkb1ÿ /ÿ livers and
7 (including nfkb1) were downregulated in comparison to wt
Table 1 | Pro-inflammatory phenotypes in wt and nfkb1ÿ /ÿ mice.
Phenotype nfkb1ÿ /ÿ (12 weeks) nfkb1ÿ /ÿ (36 weeks) wt (12 weeks) wt (36 weeks) wt (104 weeks) wt (132 weeks)
Enlarged spleen* 3/5 6/6 0/5 0/5 1/7 4/5
High systemic IL-6w 0/5 5/5 0/4 2/5 n.d. 5/5
Liver: immune cell infiltrationz 1/5 5/5 0/5 0/5 n.d. 2/3
Data are no. of animals showing the phenotype/no. of animals observed.
*Spleen mass 40.35% of body mass
w46 pgmlÿ 1
z46 CD3þ cells per field
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mice at the same age (Fig. 1h). Even at twice this age (72 weeks),
considerably fewer NF-kB target genes (nine up and two down;
Fig. 1h) were induced in wt mice. Fifty-one out of 80 tested pro-
inflammatory cytokines, chemokines, immunoreceptors and cell
adhesion molecules were measurably expressed (by antibody
array) in wt and/or nfkb1ÿ /ÿ livers. Of these, 25 were more
abundant (Po0.10, t-test) in nfkb1ÿ /ÿ livers, while only 3
tended to be less abundant (Fig. 1i). Upregulation of 10 out of 15
NF-kB target genes from Fig. 1h was confirmed at the protein
level (Fig. 1i). Certain pro-inflammatory cytokines, for example,
TNF-a, were already upregulated at a very young age (12 weeks)
in liver (Supplementary Fig. 1). Together with published
results21–23 these data show that chronic systemic inflammation
in nfkb1ÿ /ÿ mice progresses with age.
Accelerated ageing in nfkb1ÿ /ÿ mice. As chronic inflammation
had been linked to ageing1,2, we investigated whether nfkb1ÿ /ÿ
mice might age faster than their wt counterparts. We tested a
wide range of biomarkers of mouse ageing in nfkb1ÿ /ÿ mice at
18 weeks
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Figure 1 | Loss of nfkb1 induces an inflammatory phenotype in mice. All data are mean (M)±s.e.m., 5–6 animals per group, if not otherwise indicated.
Significant differences (ANOVA, Po0.05) to young animals are indicated by *, and between wt and nfkb1ÿ /ÿ strains at the same age group by #. (a) IL-6
levels in blood plasma as measured by ELISA at the indicated ages. (b) White pulp (WP) and germinal center (GC) volume densities measured on spleen
H&E images at 36 weeks of age. (c) Representative CD3 immunohistochemistry at 36 weeks of age showing increased immune cell infiltrations (arrows) in
lung (top), kidney (middle) and liver (bottom) of nfkb1ÿ /ÿ , but not wt, mice. (d) Frequencies of CD3-positive cells in livers at the indicated ages.
(e) Frequencies of CD3-positive cells in livers at 32 weeks of age following treatment of mice with ibuprofen or vehicle for 8 weeks. (f) Frequencies of
CD3-positive cells in livers at 12 weeks of age following treatment of mice with the antioxidant BHA or vehicle for 4 weeks. (g) Representative a smooth
muscle cell actin (a-SMA) immunohistochemistry showing increased pro-fibrotic activity in livers from nfkb1ÿ /ÿ mice. (h) Expression of NF-kB target
genes in liver (qPCR array) at the indicated ages, n¼4 per group. All genes that are significantly changed (Po0.05) in at least one group are shown.
(i) Cytokine expression pattern in liver at 36 weeks of age, n¼4 per group. Green star indicates proteins upregulated in nfkb1ÿ /ÿ (Po0.10, t-test), red
star indicates that mRNA upregulation (h) was confirmed at protein level, black star indicates that mRNA upregulation was not confirmed at protein level.
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36 weeks of age, their C57Bl/6 littermates at the same age and in
old C57Bl/6 mice at 104 and 132 weeks (Table 2). With the
exception of indicators of muscle weakness (ataxia, sarcopenia
and kyphosis) and of spontaneous tumours, all tested biomarkers
of ageing were more frequently positive in 36-week-old nfkb1ÿ /ÿ
mice as in their wt counterparts and often reached levels similar
to wt mice aged Z2 years (Table 2). Both mean and maximum
lifespan were reduced in nfkb1ÿ /ÿ mice (Fig. 2a). AtB36 weeks
of age, adult nfkb1ÿ /ÿ mice showed frequent hair loss, early hair
greying (starting at B20 weeks of age), scruffy fur and cachexia,
comparable to wt mice aged 104 weeks or older (Fig. 2b and
Table 2). In older nfkb1ÿ /ÿ mice (ages above 44 weeks) massive
hair loss, severe skin inflammation and delayed wound healing
together with kyphosis (evidencing muscle loss) was occasionally
seen (Supplementary Fig. 2a). Body mass curves in ageing mice
show a typical convex curve with a continuous loss of body mass
from a maximum achieved at mid-life. Nfkb1ÿ /ÿ mice reached
their maximum body weights already at B36 weeks of age and
showed premature body mass loss thereafter (Fig. 2c). Improved
maintenance of body fat at mean and advanced age predicts
lifespan in mice24. Middle-aged nfkb1ÿ /ÿ mice (36 weeks of age)
evidenced loss of fat from inguinal (subcutaneous), epididymal
and mesenteric depots (Supplementary Fig. 2b). Thinning of the
epidermis is another characteristic age-associated phenotype in
mice. In nfkb1ÿ /ÿ mice at 36 weeks of age, epidermal thickness
was decreased to values found in 60-week-old wt mice (Fig. 2d).
Finally, nfkb1ÿ /ÿ mice lost neuromuscular coordination far
earlier than wt mice (Fig. 2e). Thus, nfkb1ÿ /ÿ mice aged
prematurely in multiple organ systems.
Impaired tissue regeneration in nfkb1ÿ /ÿ mice. NF-kB-
mediated inflammation can stimulate cell proliferation, especially
of tumour cells25. Conversely, NF-kB is also involved in apoptosis
signalling, and NF-kB-driven signalling can stabilize senescent
cell arrest in vitro14,16. To understand how NF-kB-driven chronic
inflammation can cause accelerated ageing in mice, we first
analysed its impact on tissue regeneration. Partial hepatectomy
stimulates liver regeneration in wt mice. Hepatocyte proliferation
after partial hepatectomy in nfkb1ÿ /ÿ mice was drastically
reduced (Fig. 3a,b) to levels typically found in aged wt mice26.
However, hepatocyte apoptosis was not enhanced in nfkb1ÿ /ÿ
livers (Supplementary Fig. 3a). Treatment of mice with the anti-
inflammatory drug ibuprofen for 1 month before partial
hepatectomy completely restored regenerative capacity of
hepatocytes in the context of nfkb1ÿ /ÿ (Fig. 3a,b).
Inflammation is frequently associated with enhanced ROS
production and increased oxidative damage27. To test whether
decreased liver regenerative capacity in nfkb1ÿ /ÿ was mediated
by ROS, mice were treated with the antioxidant BHA before
partial hepatectomy. Like ibuprofen, BHA had no effect on
hepatocyte proliferation in wt mice, but fully rescued the
decreased regenerative potential in nfkb1ÿ /ÿ livers (Fig. 3c).
The gut epithelium is constantly regenerated from stem cells
located at the bottom of the crypts. Low mucosal thickness of the
colon and low villus length in the intestine are early morpho-
logical indicators of decreasing stem/progenitor function in the
ageing gut, leading to malabsorption28. Both parameters were
decreased in nfkb1ÿ /ÿ mice aged 36 weeks (Fig. 3d,e) to values
similar to those in 52–104-week-old wt mice28. This was not
associated with enhanced apoptosis (Supplementary Fig. 3b),
suggesting a decreased regenerative capacity in either stem or
progenitor cells. To address this, we isolated intestinal crypts
from 12- and 54-week-old mice and analysed their growth in
organotypic culture over a 10-day observation period (Fig. 3f).
We measured both the frequencies of crypts that started to grow,
which is indicative of stem cell function, and growth rates,
indicative of proliferation primarily in the progenitor cell
compartment. Crypts isolated from young nfkb1ÿ /ÿ mice
maintained both the ability to grow (Fig. 3g) and growth rates
(Fig. 3h) as well as wt crypts. In 54-week-old wt mice (B44% of
median lifespan), the stem cell-related regenerative potential of
intestinal crypts was compromised (Fig. 3g), while progenitor
replicative capacity was still intact (Fig. 3h). In 54-week-old
nfkb1ÿ /ÿ mice (64% of median lifespan) both stem and
progenitor cell function in the intestinal crypts were decreased
(Fig. 3g,h). Ibuprofen treatment had no effect on crypt stem cell
function from young mice of either genotype. However, it
Table 2 | Ageing-associated phenotypes in wt and nfkb1ÿ /ÿ mice.
Phenotype nfkb1ÿ /ÿ (36 weeks) wt (36 weeks) wt (104 weeks) wt (132 weeks)
Low coat quality score* 8/14 0/15 7/12 4/6
Low body condition scorew 13/14 3/15 9/12 5/6
Low welfare status scorez 7/14 0/15 9/12 4/6
Ataxia 1/14 1/15 3/12 3/6
kyphosis 0/9 0/15 0/12 0/6
sarcopeniay 0/6 0/6 2/6 4/4
Terminal weight loss|| 3/8 0/24 6/19 8/9
Low total body fatz 6/6 0/5 0/5 4/5
Low subcutaneous fat# 5/6 0/5 3/7 5/5
Cardiac hypertrophy** 3/6 0/5 0/6 4/5
Liver: lipofuscin 2/3 1/8 1/4 6/6
Liver: karyomegalyww 4/5 1/5 3/3 3/3
Brain: lipofuscin 2/5 0/7 n.d. 4/4
Macroscopic tumours 0/6 0/7 3/7 7/11
death 6/23 0/52 15/52 34/52
Data are no. of animals showing the phenotype/no. of animals observed.
*Alopecia, hair greying, piloerection, fur roughness scored at a scale from 1 to 10, scores below 7 are counted as low.
wBody condition67 scored at a scale from 1 to 10, scores below 7 are counted as low.
zPhysical, physiological and psychological status scored according to Hawkins et al.68 at a scale from 1 to 10, scores below 7 are counted as low.
yMean hind leg muscle fibre diameter o36 mm
||Weight 43 g below max for 41 month
zTotal body fat¼ Sum (inguinalþ epidymalþ perirenalþmesenteric) o5% of BW
#Subcutaneous fat o0.7 g
**Heart mass 40.55% of BW
ww410% of hepatocyte nuclei
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improved growth rates of crypts from nfkb1ÿ /ÿ mice (Fig. 3h),
suggesting that chronic inflammation in nfkb1ÿ /ÿ mice limits
the proliferative potential of crypt transient amplifying cells in
adulthood.
Chronic inflammation reinforces cellular senescence. As loss of
nfkb1 limited tissue regeneration without enhancing apoptosis
and because NF-kB-driven cytokine signalling can reinforce cell
senescence in vitro13,14,16, we hypothesized that chronic
inflammation might aggravate the senescent phenotype and
thus limit tissue regeneration.
Mouse fibroblasts senesce spontaneously after few population
doublings in 21% ambient oxygen as a consequence of a stress-
induced DDR29. Mouse adult ear fibroblasts (MAFs) from
nfkb1ÿ /ÿ donors senesced faster than their wt counterparts as
indicated by accelerated loss of proliferative capacity (Fig. 4a) and
increased expression of the senescence marker senescence-
associated b-galactosidase (sen-b-gal; Fig. 4b). To address the
underlying mechanisms of accelerated senescence in nfkb1ÿ /ÿ
cells, we used a well-established model of induction of cell
senescence by ionizing radiation (IR)12,30. Radiation-induced
DDR can activate NF-kB through an ATM-dependent
mechanism31. However, the immediate response to DNA
damage was not different between nfkb1ÿ /ÿ and wt MAFs as
shown by equal activation of ATM (Fig. 4c and Supplementary
Fig. 4a) and p53 (Supplementary Fig. 4a) and equal frequencies of
DNA damage foci within 1 day after IR (Supplementary Fig. 4b).
Similarly, there was no difference in the abundance of the NF-kB
target COX-2 (PTGS-2) immediately after IR (Supplementary
Fig. 4a, see also Supplementary Fig. 7).
It is well established that the induction of the senescent
phenotype including sen-b-Gal, SASP and enhanced ROS produc-
tion requires at least 3–7 days following IR12,15. Multiple feedback
loops interconnecting the DDR with SASP and ROS phenotypes via
p38MAPK and NF-kB have been described12–14,32,33, all of them
stabilizing senescence with some kinetic delay. Accordingly, after a
sufficient delay following IR, a wide range of senescence markers
was elevated in both wt and nfkb1ÿ /ÿ MAFs. Importantly, the
senescent phenotype was aggravated in nfkb1ÿ /ÿ cells according
to every single marker tested (Fig. 4d-g and Supplementary Fig.
4c–h). Specifically, there were more sen-b-Gal-positive cells
(Fig. 4d), more DNA damage foci per nucleus (Fig. 4e), more
mitochondrial superoxide was produced per cell (Fig. 4f), more
ROS accumulated in the cytoplasm (Supplementary Fig. 4c) and the
expression of the CDKN1A and CDKN2A genes encoding the
major cyclin-dependent kinase inhibitors p21 and p16 was more
strongly upregulated in induced senescence in nfkb1ÿ /ÿ MAFs
(Supplementary Fig. 4d). The SASP was also stronger in nfkb1ÿ /ÿ
MAFs: A cytokine array confirmed enhanced secretion of 36 SASP
components in induced senescence in wt MAFs (Supplementary
Fig. 4e). Of these, 13 were more abundant in the supernatant of
senescent nfkb1ÿ /ÿ MAFs, while only 6 were less abundant.
Moreover, anti-inflammatory cytokines (IL-4 and IL-10) were more
robustly downregulated in nfkb1ÿ /ÿ MAFs (Supplementary
Fig. 4e), together indicating an enhanced SASP in senescent
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Figure 2 | Premature ageing of nfkb1ÿ /ÿ mice. (a) Kaplan–Meier survival curves (right censored) of wt and nfkb1ÿ /ÿ mice, log-rank test, nZ27.
(b) Representative images of wt mice and an nfkb1ÿ /ÿ mouse at the indicated ages showing premature hair greying and scruffy fur in nfkb1ÿ /ÿ mice.
(c) Age at maximum body weight in nfkb1ÿ /ÿ and wt mice (n¼ 56 for wt, n¼ 8 for nfkb1ÿ /ÿ , Po0.05, t-test). (d) Representative skin sections of
36-week-old animals, H&E stain. Boxed areas are shown at higher magnification. Mean epidermal thickness at the indicated ages is shown on the right
(nZ5). (e) Neuromuscular coordination measured as number of unsuccessful attempts to remain on a straight rod for 60 s (n¼ 6 to 10 per group). All data
are M±s.e.m. Significant differences (ANOVA with post hoc Holm–Sidak test, Po0.05) to respective controls of the same genotype are indicated by *, and
between wt and nfkb1ÿ /ÿ strains at the same treatment by #.
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nfkb1ÿ /ÿ fibroblasts. We confirmed upregulation in senescent
nfkb1ÿ /ÿ fibroblasts over wt for the major pro-inflammatory NF-
kB targets IL-6 by ELISA (Supplementary Fig. 4f) and TNF-a by
qRT–PCR (Supplementary Fig. 4g). In accordance with all other
markers, ATM/ATR foci were also more frequent in nfkb1ÿ /ÿ
MAFs at 10 days after IR (Supplementary Fig. 4h).
To understand the mechanisms by which chronic pro-
inflammatory signals increased senescence-associated mitochon-
drial ROS production we first tested the role of p38MAPK.
Signalling through p38MAPK drives enhanced mitochondrial
ROS12 and activates NF-kB17 in senescence. Accordingly,
inhibition of p38MAPK using SB203580 effectively reduced
ROS production in senescent wt MAFs but was much less
effective in senescent nfkb1ÿ /ÿ cells in which NF-kB is
constitutively activated independent of p38MAPK (Fig. 4f). In
contrast, treatment with the NSAID ibuprofen, which acts
preferentially by inhibition of prostaglandin synthesis driven by
cyclooxygenases COX-1 and COX-2 (ref. 34), had no effect in wt
MAFs but efficiently reduced frequencies of sen-b-Gal-positive
cells (Fig. 4d), DNA damage foci frequencies (Fig. 4e) and
mitochondrial superoxide (Fig. 4f) in senescent nfkb1ÿ /ÿ MAFs.
COX-2 expression was upregulated in senescence, more so in
nfkb1ÿ /ÿ MAFs than in wt cells (Fig. 4g). Prostaglandin E2,
which is synthesized by COX-2, increases in senescence and can
induce and maintain multiple markers of the senescent
phenotype35. Inhibition of COX-2 by the specific inhibitor
NS-398 mimicked the effect of ibuprofen by reducing sen-b-
Gal-positive cells (Fig. 4d), the DDR (Fig. 4h and Supplementary
Fig. 4h) and cellular ROS levels (Fig. 4i) specifically in nfkb1ÿ /ÿ
MAFs. Accordingly, knockdown of COX-2 by two separate
siRNAs (Supplementary Fig. 4i) reduced DNA damage foci
frequencies (Fig. 4j) and ROS levels (Fig. 4k) exclusively in
nfkb1ÿ /ÿ MAFs. A similar reduction of the DDR was obtained
by treating nfkb1ÿ /ÿ , but not wt, MAFs with the antioxidant
NAC (Supplementary Fig. 4j). Together, these data show that loss
of nfkb1 stabilizes cell senescence by aggravating mitochondrial
ROS production via COX-2 activation and, consequently,
enhancing nuclear DDR.
Senescence is not a cell-autonomous process. By secreting
bioactive molecules including interleukins, chemokines and
ROS12,15, senescent cells induce powerful bystander effects that
spread senescence to neighbouring normal cells36,37. Given that
both ROS and SASP signals are stronger in nfkb1ÿ /ÿ cells, we
hypothesized that these cells, when senescent, might exert a
stronger bystander effect. We tested this assumption by
co-culture of nfkb1ÿ /ÿ fibroblasts with reporter cells in which
a GFP-53BP1 fusion protein allowed kinetic monitoring of the
DDR specifically in bystander cells36 (Fig. 4l). As expected,
senescent nfkb1ÿ /ÿ MAFs induced more DNA damage in
bystander cells than senescent wt MAFs (Fig. 4m,n). This shows
that loss of nfkb1 reinforces cellular senescence by both autocrine
and paracrine signalling. We therefore expected faster
accumulation of senescent cells in tissues from nfkb1ÿ /ÿ mice.
Feedback between inflammation and telomere dysfunction in vivo.
Telomere dysfunction is an important driver of cell senescence38,
and TAF (Fig. 5a,b) are established as markers of telomere
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dysfunction and cell senescence in human and mouse tissues9,11,39–
41. TAF frequencies increased with age in liver hepatocytes and in
enterocytes in intestinal crypts from wt mice (Fig. 5c,d) similar to
other markers of cell senescence11,42,43. TAF frequencies were always
higher in nfkb1ÿ /ÿ mice (Fig. 5c,d), reaching levels similar to those
found in late-generation tercÿ /ÿ mice (Supplementary Fig. 5a), a
well-established model for telomere dysfunction-driven
senescence10,12. As expected for dysfunctional telomeres, chromatin
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bridges were observed between hepatocyte nuclei in nfkb1ÿ /ÿ livers
following partial hepatectomy (Supplementary Fig. 5b). To test
whether the increase of TAF-positive cells was caused by
inflammation rather than some other effect of p105/p50 deficiency,
we first treated nfkb1ÿ /ÿ mice for 8 weeks with the NSAID
ibuprofen. Ibuprofen has complex, context-dependent effects on
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expression of pro-inflammatory cytokines44,45, but robustly
suppresses systemic COX activity34. Enhanced TAF frequencies in
nfkb1ÿ /ÿ tissues were completely prevented by this treatment
(Fig. 5c,d). To further verify the causal role of inflammation for
induction of telomere dysfunction in vivo, we measured TAF
frequencies in livers from an independent transgenic model of
chronic inflammation. p55Dns knock-in mice express a mutated
TNFR1 ectodomain that is incapable of shedding, leading to chronic
activation of TNF-a signalling and chronic low-grade inflammation
specifically in the liver46. As this phenotype is confined to the liver46,
it did not cause obvious progeria in the mice. However, p55Dns/Dns
livers showed hepatocyte TAF frequencies higher than in wt and
similar to those in nfkb1ÿ /ÿ livers (Fig. 5e), and mRNA expression
of the senescence marker CDKN2A (p16) was increased in p55Dns/
Dns livers (Supplementary Fig. 5c). Together, these data show that
telomere dysfunctional cells accumulate in different mouse models of
chronic inflammation.
Telomere dysfunction in nfkb1ÿ /ÿ mice was not associated
with shortened telomere length (Supplementary Fig. 5d). More-
over, telomerase interacts with NF-kB in a positive feedback
loop47 and therefore tended to be downregulated under ibuprofen
in nfkb1ÿ /ÿ mice (Supplementary Fig. 5e), excluding improved
protection of telomeres by telomerase as a cause of ibuprofen-
mediated rescue of telomere dysfunction.
However, telomeres are exquisitely sensitive to damage by
ROS, generated extrinsically39 or intrinsically11,48 as a by-product
of normal cellular metabolism. In cell senescence, ROS
production is enhanced, generating DNA damage and
increasing the DDR in a positive feed-forward loop12. This loop
is aggravated by telomere dysfunction, as seen in late generation
tercÿ /ÿ mice12,49 and in nfkb1ÿ /ÿ cell senescence in vitro
(Fig. 4). Accordingly, oxidative stress as measured by
accumulation of 4-HNE, a marker for lipid peroxidation, was
increased in nfkb1ÿ /ÿ livers (Fig. 5f,g) as well as broadband
autofluorescence, another marker of oxidative damage
(Supplementary Fig. 5f). 4-HNE-positive hepatocytes in
nfkb1ÿ /ÿ livers were also positive for the DNA damage- and
senescence marker gH2AX (Fig. 5h). Importantly, treatment of
mice for 4 weeks with the antioxidant BHA rescued the TAF
increase mediated by knockout of nfkb1 (Fig. 5i). Additional
markers of cell senescence including frequencies of gH2AXþ
PCNAÿ cells42 (Supplementary Fig. 5g), frequencies of ATM/
ATR-positive cells (Supplementary Fig. 5h) and nuclear size
(Supplementary Fig. 5i) were also enhanced in hepatocytes from
ageing nfkb1ÿ /ÿ mice. Moreover, there was a strong preference
of 4-HNE-positive hepatocytes to form clusters in nfkb1ÿ /ÿ
livers (Supplementary Fig. 5j,k) as expected if a bystander effect
contributed to senescent cell accumulation36. Together, these data
show that, like nfkb1ÿ /ÿ fibroblasts in vitro, nfkb1ÿ /ÿ
hepatocytes in vivo are more prone to senesce, driven by
positive feedback between ROS production and DDR and
involving telomere dysfunction. This was not restricted to the
liver; frequencies of gH2AXþ PCNAÿ cells were similarly
enhanced in intestinal crypts (Supplementary Fig. 5l). In
intestinal crypts, both TAF analysis (Supplementary Fig. 5m)
and gH2AX/PCNA immunofluorescence (not shown) localized
senescent enterocytes preferentially around the position of the
transient amplifying cells, suggesting preferential exhaustion of
progenitor cells. Cells with an activated DDR were also more
abundant in other tissues from nfkb1ÿ /ÿ mice including heart,
colon and spleen (not shown).
As expected, COX-2 was upregulated in nfkb1ÿ /ÿ livers while
major antioxidant enzymes including GPX4, Prdx1, GSTK1,
Txnrd2 and the Nrf2 transcriptional targets AOX1 and GCLC
were downregulated (Fig. 5j). As in MAFs, COX-2 upregulation is
specific to nfkb1ÿ /ÿ mice, while antioxidant downregulation is
shared in livers from late-generation tercÿ /ÿ mice (Fig. 5j), in
which increased cellular ROS production is caused by a DDR
triggered by dysfunctional telomeres12,49.
Having shown enhanced telomere dysfunction and senescence
in two different models of chronic inflammation in vivo, we
investigated whether conversely telomere dysfunction would lead
to a pro-inflammatory state, for example, in tissues from late-
generation tercÿ /ÿ mice. This was in fact the case: NF-kB
activity, measured as the amount of TNF-a promoter DNA
precipitated using an anti-p65 antibody, was equally enhanced in
nfkb1ÿ /ÿ and late-generation tercÿ /ÿ livers (Fig. 5k). More-
over, out of 78 tested NF-kB target genes, the expression of 39
genes was significantly changed in late-generation tercÿ /ÿ livers,
with the majority (24 genes) upregulated in tercÿ /ÿ (Fig. 4l).
The overlap in NF-kB target gene regulation between tercÿ /ÿ
and nfkb1ÿ /ÿ livers was considerable: 15 genes were equally
regulated in tercÿ /ÿ and nfkb1ÿ /ÿ , while only 4 genes were
changed in the opposite direction in both models (compare
Figs 1h and 5l).
Together these data suggest that there exists a positive feedback
loop system between telomere dysfunction, senescence-associated
ROS production and pro-inflammatory signalling that induces
and stabilizes senescence in vivo, which in turn limits regenerative
capacity of tissues.
Frequencies of senescent cells in sensitive tissues predict lifespan.
Continuous regeneration is an essential feature of life. If telomere
dysfunction and associated cell senescence is a major limitation to
tissue regeneration one should expect that accumulation of
senescent cells might quantitatively predict lifespan in mice.
To test this assumption we used cohorts of mice that differed
almost threefold in their maximum (Fig. 6a) and median
(Supplementary Fig. 6a) lifespan while being kept under identical
housing conditions in our dedicated ageing mice unit. Lifespan
differences were due to either genetic (nfkb1ÿ /ÿ , late-generation
tercÿ /ÿ ) or environmental (dietary restriction) intervention or
to selected breeding (ICRFa). Senescent cell frequencies in crypt
enterocytes and centrilobular hepatocytes were measured at
different ages using multiple markers. We counted g-H2AXþ
PCNAÿ cells, TAFþ cells (separated into cells with41TAF and
with 42TAFs), sen-b-Galþ cells and (in liver only) 4-HNEþ
cells as markers of senescence. Surprisingly, senescent cell
frequencies over all disparate ageing models fitted well into the
same linear correlation with relative age, calculated as the
percentage of maximum lifespan of the strain (Fig. 6b–f and
Supplementary Fig. 6b). Similarly strong correlations were found
if age was calculated as percentage of median lifespan
(Supplementary Fig. 6c,d). A comparison between the different
markers showed that 41TAF and 42TAF data flanked the
g-H2AXþPCNAÿ , Sen-b-Galþ and 4-HNEþ estimates on both
sides, indicating that the minimum number of TAF associated with
cell senescence is between 2 and 3 in both hepatocytes and
enterocytes. 4-HNE, measuring a specific lipid peroxidation pro-
duct, is arguably the most indirect marker of senescence, which
might explain why it showed the largest variation between mouse
models.
To assess the strength of the quantitative association between
senescent cell accumulation and lifespan, we calculated accumu-
lation rates for senescent cells over time separately for each of the
mouse models and each marker. These data linearly predict
maximum (Fig. 6g,h) and median lifespan (Supplementary
Fig. 6e,f). Interestingly, quantitative predictions are very similar
for liver and gut. Whether this indicates that there is an upper
frequency of senescent cells that can be tolerated in any tissue
compartment awaits further examination.
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Discussion
Tissue repair and regeneration are of prime importance for the
maintenance of tissue homeostasis during ageing. They are
dependent on maintaining functional capacity in tissue-specific
stem and progenitor cells, but this functionality is known to
decrease with ageing in multiple tissues, caused at least partially
by activation of DNA damage checkpoints50–52. As exemplified
by repair of infected or otherwise damaged tissue, inflammation is
often an essential component of tissue regeneration. Here we
suggest that failure to resolve the former impairs the latter
because inflammation causes DNA damage and, especially,
telomere dysfunction, which is a potent activator of persistent
DNA damage checkpoint activity. Pro-inflammatory signals can
cause telomere dysfunction because they are closely integrated in
multiple positive feedback loops with stress and nutrient
signalling pathways (involving p38MAPK, TGF-b, mTOR and
others) that contribute to control of mitochondrial function and
ROS production12–14,17. Specifically, our data show a major role
for the NF-kB target COX-2 in instigating oxidative stress, which
in turn contributes to induction and maintenance of a DDR.
Telomeres are preferential sites for DNA damage
accumulation11,39, because they are deficient for various types
of DNA repair53,54. Thus, inflammation acting chronically in vivo
aggravates telomere dysfunction by increasing oxidative stress at
least partially through COX-2 activation. This then accelerates
accumulation of senescent cells, which intensifies pro-
inflammatory and pro-oxidant signalling by the SASP
response13,32 and by induction of mitochondrial dysfunction55,
spreading DNA damage and senescence towards bystander
cells36,37. Interestingly, we found a pro-inflammatory phenotype
in nfkb1ÿ /ÿ cells in vitro (in terms of secreted cytokines, COX-2
expression and ROS production) only after induction of
senescence (Fig. 4). Together with the increased frequencies of
senescent cells in nfkb1ÿ /ÿ tissues (Figs 5 and 6) this suggests
that aggravated cell senescence could at least partly be
instrumental for the establishment of ‘classical’ inflammatory
phenotypes like immune cell infiltration into solid organs. Both
recent intervention studies18 and our correlative data presented
here strongly underscore the importance of cell senescence for
determination of ageing rate and lifespan in mammals. Tissue
resident stem cells51,52 and fast proliferating progenitors might be
most sensitive to the consequences of DNA damage checkpoint
activation and thus organ repair becomes increasingly suboptimal
with ageing.
A limitation of our study is that we did not attempt to rescue
lifespan in nfkb1ÿ /ÿ mice by anti-inflammatory treatment
because of the known long-term side effects of NSAIDs like
ibuprofen34. However, medium-term (1–2 months) treatment of
mice with either ibuprofen or the antioxidant BHA rescued
telomere dysfunction and regenerative capacity in the nfkb1ÿ /ÿ
background. Moreover, long-term treatment with the NSAID
aspirin prolonged lifespan in genetically heterogeneous wt mice56.
Taken together, our data suggest that loss of regenerative
potential and accelerated ageing in nfkb1ÿ /ÿ mice are due to
chronic activation of the NF-kB–COX-2–ROS axis causing
accelerated and aggravated cell senescence in multiple tissues.
NF-kB activity, COX-2 expression and ROS levels are also
elevated in late generation tercÿ /ÿ mice, in which progeria is
driven by telomere dysfunction causing apoptosis and senescence.
This indicates that pro-inflammatory signals, ROS, persistent
DDR and senescence are interconnected in positive feedback
loop(s) not only in vitro12–14,17 but also in vivo. The fact that
senescent cell accumulation quantitatively predicts lifespan not
only for progeroid but also for long-lived mouse models suggests
that feedback between inflammation, ROS and cell senescence
might be a general determinant of the rate of ageing in mammals.
Our findings may have implications for human ageing in the
context of many, if not all, of the modern chronic disease states.
Type II diabetes, liver disease, arthritis, CVD, metabolic
syndrome or dementia, to name just a few, have in common
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Figure 6 | Accumulation of senescent cells predicts lifespan in mice over
a wide range of interventions. (a) Maximum lifespan of males in different
cohorts of mice under AL feeding and dietary restriction (DR). See Methods
for cohort description. (b–f) Frequencies of senescent centrilobular
hepatocytes measured as gH2AXþ PCNAÿ cells (b), cells with 41 TAF
(c), with42TAFs (d), Sen-b-Gal positive cells (e) or 4-HNE- positive cells
(f) versus relative age (calculated as % of maximum lifespan completed).
Symbol colours indicate the same strains as in (a), triangle indicates a
strain under dietary restriction. Data are M±s.e.m. from at least 3 mice per
age group. (g) Maximum lifespan per cohort versus rate of accumulation of
senescent hepatocytes, calculated by linear regression of senescent cell
frequencies against age. Symbol outlines indicate strain/condition as
before. Symbol fills indicate the senescence marker used: outline colour:
g-H2AXþ PCNAÿ , pink: sen-b-Gal, white: 41TAF, grey: 42TAFs.
(h) Maximum lifespan versus rate of accumulation of senescent crypt
enterocytes. Symbols as before.
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that ageing is the major risk factor. Moreover, they are associated
with chronic low-grade inflammation (or ‘parainflammation’)
and, possibly, with cell senescence57. Our data suggest that once
systemic inflammation is established, for example, in
consequence of any single disease, ageing in multiple organ
systems might accelerate, and this would increase the risk for
multimorbidity. There is epidemiological evidence that
prevalence of a chronic disease is a significant risk factor for
incidence of additional, often multiple age-associated
degenerative diseases58. Multimorbidity, frailty and mortality in
the elderly are all associated with markers of chronic systemic
inflammation59,60. Our data suggest that long-term anti-
inflammatory intervention in elderly patients with age-
associated degenerative disease might reduce steady-state levels
of senescent cells, which could have preventive potential. Finally,
our data show that mouse models for chronic inflammation like
the nfkb1ÿ /ÿ mouse provide a model for further interrogating
these mechanisms and testing the ‘anti-ageing’ potential for
interventions such as anti-inflammatory drugs or lifestyle
modifications that have an impact on the inflammatory process.
Methods
Animals. Experiments were performed on male nfkb1ÿ /ÿ mice on a pure C57Bl/
6 background and C57Bl/6 wt controls. Pure background mice were a gift from
Jorge Caamano, (Birmingham University, UK). Experiments were performed at 36
weeks of age if not indicated otherwise. Immunohistochemistry was also performed
on mixed C57Bl/6;129PF2/J nfkb1ÿ /ÿ and F2 hybrid nfkb1þ /þ wt control mice
(Jackson Laboratories, Bar Harbor, ME, USA) with identical results. p55Dns/Dns
mice and their wt littermate controls have been described46. Male late-generation
(F3–F4) tercÿ /ÿ mice were bred from B6/Cg-TERCtm1Rdp/J (Jackson
Laboratories). Lifespan studies were also performed in male C57Bl/6 under ad
libitum feeding (AL) and under dietary restriction (DR, 60% of AL intake)61 and in
male ICRFa (a long-lived substrain of C57Bl/6)62. Mice were housed in cages
(56 cm 38 cm 18 cm, North Kent Plastics, Kent, UK) of groups of 4–6 that did
not change from weaning. Mice were provided with saw dust and paper bedding
and had AL access to water. Mice were housed at 20±2 °C under a 12 h light/12 h
dark photoperiod with lights on at 07:00 hours. Group sizes for lifespan
experiments were (censored events in brackets): nfkb1ÿ /ÿ 27 (18), C57Bl/6 AL
310 (172), C57Bl/6 DR 241 (157), IRCFa 2391 (1,061) and F3TERCÿ /ÿ 13 (0).
Maximum lifespan was estimated as the lifespan of the longest living 1–3% of the
cohort. Medians were calculated from right-censored Kaplan–Meier curves. Ethical
approval was granted by the LERC Newcastle University, UK. All experiments were
undertaken in compliance with UK Home Office legislation under the Animals
(Scientific Procedures) Act 1986. Organs were either fixed in 4% paraformaldehyde
or snap-frozen in liquid nitrogen and stored at ÿ 80 °C. Telomerase activity was
measured by TeloTAGGG Telomerase PCR ELISA kit (Roche). Fixed tissues were
processed and embedded in paraffin. All sections were cut at a thickness of 3 mm.
70% partial hepatectomy (PHX) was performed in 12–week-old mice according
to the method of Higgins and Anderson63.
Ibuprofen and BHA treatment. For liver and gut regeneration studies, mice were
given ibuprofen mixed in their food to a daily dosage of 50mg per kg (mouse) per
day. Treatment started at 8 weeks of age for 4 consecutive weeks. For senescence
studies, mice received ibuprofen via pump (mini-osmotic pump, Alzet, model
2004) for a period of 8 weeks (starting at 24 weeks of age). Ibuprofen was dissolved
in PEG and DMSO (50:50) to a daily dosage of 50mg per kg. A small incision was
made on the right flank and a mini pump was inserted subcutaneously and the
wound was repaired with 7mm clips. After 28 days a replacement was implanted.
Under general anaesthesia, pumps were surgically removed and a wound repair
was performed. A small incision was made on the left flank and a new mini pump
was inserted subcutaneously and the wound was repaired with 7mm clips. 8-week-
old wt or nfkb1ÿ /ÿ mice were fed BHA (0.7% w/w) or normal chow for 4 weeks
before undergoing partial hepatectomy.
Neuromuscular coordination. The tightrope test is a widely used and extensively
validated marker of ageing and shows differences in neuromuscular coordination64.
The mice were placed on a horizontal bar with a diameter of 1.5 cm and a length of
60 cm. The time spent on top of the bar was recorded. A trial was considered
successful if the animal could remain on the bar for 60 s without falling off. Each
mouse was given five consecutive trials.
Cell culture. Ear clippings were transported and stored (not longer than 1 h) in
DMEM containing serum on ice. Punches were washed three times with serum-
free media, finely cut and incubated for 2–3 h at 37 °C in 2mgmlÿ 1 collagenase A
in DMEM. A single-cell suspension was obtained by repeated pipetting and passing
through a 24G fine needle. Cells were centrifuged for 10min at 1,000 r.p.m. and
cultured in Advanced DMEM/F-12 (DMEM, Invitrogen) plus 10% fetal calf serum
(Sigma) in 3% O2 and 5% CO2. Each cell strain was derived from a separate donor.
MAFs were seeded and allowed to grow for 24 h, then X-ray-irradiated with 10 Gy
using a PXI X-Rad 225 (RPS Services Ltd). Immediately following irradiation,
media was replaced.
Cells were treated with 10 nM siRNA (Qiagen, SI101392391, SI01392398 or no.
1027281) at 1 day before IR in HiPerFect (Qiagen). Ibuprofen (Sigma, no. I7905-
1G, 0.2mM) was added to the cell culture media immediately after IR. Inhibitors
were used from immediately after IR at the following concentrations: SB203580 at
10 mM, NS-398 at 2.5mM. To measure mitochondrial superoxide55, cells were
stained in 5 mM MitoSOX Red (Molecular Probes; http://www.invitrogen.com) for
10min at 37 °C, and FL3 median fluorescence intensity was measured by flow
cytometry (Partec PAS; http://www.partec.com). Specificity of MitoSOX for
superoxide has been shown by the manufacturer, and its mitochondrial localization
was tested by co-staining with Mitotracker Green. Cellular peroxide levels were
assessed by staining with 5 mM DHE (Molecular Probes) for 10min in the dark at
37 °C and analysis of FL3 fluorescence. Cellular ROS levels were assessed by
staining with 25mM CellROX Orange (Life Technologies) for 30min in the dark at
37 °C and analysis of FL2 fluorescence. The flow cytometer was calibrated using
fluorescent microspheres. All data are mean±s.e.m. from at least three
independent experiments with measurements in duplicate and 104 cells per
measurement.
Bystander experiments. A total of 10,000 MAFs from wt and nfkb1ÿ /ÿ mice
were X-ray-irradiated with 10 Gy. At the indicated time points, media was changed
and 10,000 human reporter cells (transduced with the AcGFP–53BP1c reporter65)
were added and co-cultured for 1 or 2 days. Cells were fixed in 2%
paraformaldehyde and stored at ÿ 80 °C until staining was performed.
Quantitative analysis of cluster probability. A total of 10–20 images per section
were taken using a  20, 0.5NA objective and tiled together. The total number of
cells (N) and the number of 4-HNE-positive cells (M) per tiled image were counted
as well as the total number of neighbours (ni) and the number of 4HNE-positive
neighbours (mi) for each of the positive cells (i¼ 1...M). To test whether a positive
cell was more likely to have positive neighbours than negative neighbours given the
prevalence of positive cells in the image (that is, whether positive cells were clus-
tered to a larger degree than expected by random chance), a hyper-geometric test
for over-representation of positive cells in the neighbourhood of each positive cell
was carried out. A P-value (pi) for over-representation was calculated for each
neighbourhood. The probabilities pi,..,M were corrected for multiple comparisons by
false discovery rate control to give q-values (qi,...,M). The fraction (F) of positive
cells having significantly more positive neighbours than expected by chance given
the background proportion of positive cells observed was estimated as36:
F ¼
# qi qio0:05j
M
ELISA. Cells were grown in 75 cm2 flasks. Two days after irradiation, medium was
replaced by fresh serum-free medium. After 24 h, media was collected, sterile-
filtered (0.4 mm pore size) and frozen at ÿ 80 °C. Cells were trypsinized, counted
and pelleted for protein concentration assay. ELISAs (Murine IL-6 ELISA Mini Kit,
PeproTech, no. 900-M50; murine TNF-a ELISA Mini Kit, PeproTech, no. 900-
M54) were performed according to the manufacturer’s instructions.
Quantibody array. Wt and nfkb1ÿ /ÿ mouse ear fibroblast (isolated from four
different mice each) were seeded in 75 cm2 flasks. Media was changed 8 days after
IR to 4ml serum-free media and collected after 2 days. Supernatant was centrifuged
for 10min at 2,000 r.p.m. at 4 °C. The supernatant (3ml) was stored at ÿ 80 °C for
analysis. Frozen livers from 12- and 36-week-old wt and nfkb1ÿ /ÿ mice were
pulverized in a liquid nitrogen-cooled mortar and pestle. Tissues were lysed using
0.5% Triton-100 in TRIS (50mM, pH 7.4) and 1 tablet of proteinase inhibitor
complete (Roche, no. 05892953001). Lysis buffer (700 ml) was added and lysate was
placed in a Qiagen shredder and centrifuged at full speed for 2min followed by
another spin for 10min at 5,000 r.p.m. at 4 °C. Supernatant was transferred in
several tubes, protein concentration was measured and samples were stored at
ÿ 80 °C. Analysis was performed by RayBiotech Inc. (Insight Biotechnology Ltd,
Wembley UK). For data analysis proteins were included if they showed expression
above background in at least two of the conditions. Using Gene Cluster 3.0, data
from the four replicates were averaged and normalized. Results were visualized in
Java TreeView.
Crosslinked chromatin immunoprecipitation assay. ChIP assay was carried out
using crosslinked chromatin prepared from wt, tercÿ /ÿ and nfkb1ÿ /ÿ livers.
Briefly, the chromatin was prepared by resuspending powdered, frozen liver in
10ml cold PBS with protease inhibitors and crosslinked with 1% formaldehyde for
5min. The reaction was stopped by adding 0.125M glycine, cells spun and pellet
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resuspended in lysis buffer (1% SDS, 10mM EDTA, 50mM Tris–HCl (pH 8.1)) for
20min before sonication for 10min (10 cycles of 30 s on, 30 s off) in Diagenode
Bioruptor. The sonicated material was spun down and chromatin-containing
supernatant was collected. Then, 25 mg of chromatin was incubated with 5 mg of
anti-p65 antibody (sc109x, Santa Cruz) or irrelevant control antibody (ab46540,
Abcam) overnight at 4° C. The complexes were collected using 50 ml of blocked
Staph A membranes, which were then serially washed, complexes eluted off and
crosslinks reversed. Genomic DNA was purified and used in quantitative PCR with
primers that span the region of interest. Each PCR reaction was performed in
triplicate and the analysis was repeated at least three times from independent ChIP
experiments. A signal intensity value for each sample was calculated from the
average of the experiments. Average values of eluates were normalized to
average values of control antibody sample and expressed as fold enrichment above
background (that is, control antibody). Quantitative PCR amplification was carried
out using primers mTNFa chip F1 50-ACACACACACCCTCCTGATT-30 and
mTNF-a chip R1 50-GCGGGGAAAAGCTCTCATC-30 .
mRNA expression analysis. RNA was isolated from frozen tissue using RNeasy
Mini Kit and QIAshredder. RNA quality was checked on the Bioanalyzer. Total
RNA was reverse-transcribed using Omniscript Reverse Transcription Kit
(Qiagen). QPCR was run in triplicates using the following primers:
p21 forward 50-TGCCAGCAGAATAAAAGGTG-30
p21 reverse 50-TTGCTCCTGTGCGGAAC-30
TNF a forward 50-ATGCGTCCAGCTGACTAAA-30
TNF a reverse 50-TCCCCTTCATCTTCCTCCTT-30
b-Actin forward 50-TAAGGCCAACCGTGAAAAG-30
b-Actin reverse 50-ACCAGAGGCATACAGGGACA-30
Cox-2—Qiagen (Mm_Ptgs2_1_SG QuantiTect primer assay, order no.: QT00165347)
qPCR array. Eighty four NF-kB target genes and oxidative stress response genes
were analysed using the RT2 Profiler PCR Array Format D (no. PAMM-225Z and
no. PAMM-065Z Qiagen) following the manufacturer’s recommendations.
Histochemistry and immunofluorescence. Paraffin sections were deparaffinized
with Histoclear and ethanol, antigen was retrieved by incubation in 0.01M citrate
buffer (pH 6.0) at 95 °C for 20min. Slides were incubated in 0.9% H2O2 for 30min
and afterwards placed in blocking buffer (Rabbit IgG, no. PK-6101; Vector Lab) for
30–60min at room temperature. Livers were further blocked with Avidin/Biotin
(Vector Lab, no. SP-2001) for 15min each. MAFs were washed briefly with PBS
and fixed for 10min with 2% paraformaldehyde dissolved in PBS. Cells were
permeabilized for 45min with PBG. Primary antibodies were applied overnight at
4 °C. Slides were washed three times with PBS and incubated for 30min with
secondary antibody (no. PK-6101; Vector Lab). Antibodies were detected using
rabbit peroxidase ABC Kit (no. PK-6101; Vector Lab) according to the manu-
facturer’s instructions. Substrate was developed using NovaRed (no. SK-4800;
Vector Lab) or DAB (no. SK4100, Vector Lab). Sections were counterstained with
haematoxylin. For IF, sections were treated as before and after the secondary
antibody incubation Fluorescein Avidin DCS (1:500 in PBS, no. A-2011, Vector
Lab) was applied for 20min. For IF on MAFs, Alexa Fluor secondary antibody
(1:2,000; Molecular Probes) was applied for 30min at room temperature. Sections
or cells were stained with DAPI for 5–10min and mounted in vectashield
mounting media.
Antibodies for IHC/IF. Anti-g-H2A.X IgG (S139) (no. 9718, rabbit monoclonal,
Cell Signaling, 1:250), anti-Ki-67 (no. ab15580, rabbit polyclonal, Abcam, 1:50),
HNE (HNEJ-2) (no. MHN-100P, mouse monoclonal, Japan Institute for the
Control of Ageing, Japan, 1:50), PCNA (no. ab29, mouse monoclonal, Abcam,
1:1,000), a-sma FITC (no. F3777, Sigma, 1:2,000), fluorescein isothiocyanate FITC
(no. P510050-8, Dako, 1:2,000), polyclonal swine anti-rabbit biotinylated (no.
E0353, Dako, 1:200), rat anti human CD3 (no. MCA1477, Serotec), goat anti rat
biotinylated secondary antibody (no. STAR80B, Serotec, 1:200), 53BP1 (no.
NB100-305, Novus Biologicals, 1:200).
Antibodies for western blotting. Phospho-ATM (Ser 1981, no. AF1655 R&D,
1:250), ATM (no. 2873 Cell Signalling, 1:500), COX-2 (no. 12282 Cell Signalling,
1:250), phospho-p53 (Ser15, no. 9284 Cell Signalling, 1:1,000), p53 (no. 9282 Cell
Signalling, 1:1,000) and GAPDH (no. 5174 Cell Signalling, 1:10,000).
Apoptotic cells were detected using ApopTag kit (no. S7100, Millipore). For
Sen-b-gal staining43, cells grown on coverslips were fixed in 2% paraformaldehyde
made up in PBS for 10min at room temperature. The cells were washed 2 3min
in PBS and then stained at 37 °C for 24 h in Sen-b-Gal staining solution containing
2mM magnesium chloride, 150mM sodium chloride, 40mM citric acid, 12mM
sodium phosphate dibasic, 5mM potassium ferrocyanide, 5mM potassium
ferricyanide and 1mgmlÿ 1 5-bromo-4-chloro-3-inolyl-b-D-galactoside (X-Gal) at
pH 5.5. The cells were washed 2 3min with PBS, counterstained with DAPI and
mounted with vectashield. Epidermal thickness was measured on H&H sections
from basement membrane to the start of the stratum corneum, ensuring
measurements were taken in interfollicular spaces.
Telomere ImmunoFISH. After g-H2A.X IF, slides were washed three times in PBS,
crosslinked with 4% paraformaldehyde for 20min and dehydrated in graded
ethanol. Sections were denatured for 10min at 80 °C in hybridization buffer (70%
formamide (Sigma), 25mM MgCl2, 0.1M Tris (pH 7.2), 5% blocking reagent
(Roche)) containing 2.5 mgmlÿ 1 Cy-3-labelled telomere-specific (CCCTAA)
peptide nucleic acid probe (Panagene), followed by hybridization for 2 h at room
temperature in the dark. Slides were washed twice with 70% formamide in 2 SSC
for 15min, followed by washes in 2 SSC and PBS for 10min. Sections were
incubated with DAPI, mounted and imaged. In depth Z stacking was used
(a minimum of 40 optical slices with  63 objective) followed by Huygens (SVI)
deconvolution. Relative telomere length was measured by telomere intensity per
nucleus in one z plane.
In vitro crypt culture. Crypt isolation was carried out as previously described66.
Crypts were then mixed with 50 ml of Matrigel (BD Biosciences) and plated in
24-well plates. The plate was then incubated at 37 °C for 15min to allow the
Matrigel to solidify. Crypt culture medium (500 ml; Advanced DMEM/F12, B27 and
N2 supplement (Invitrogen), 1.25mM N-acetylcysteine (Sigma), 50 ngmlÿ 1
murine epidermal growth factor, 100 ng mlÿ 1 murine Noggin (Peprotech),
500 ng mlÿ 1 mouse recombinant R-Spondin 1 (R&D Systems) was added to each
well. The number of crypts seeded per well was then quantified. The plate was then
transferred to a BD Biosciences Biostation where 10 crypts were randomly chosen
to be monitored every 6 h for 10 days to obtain growth curves. Crypt culture
medium was changed every 2 days and total organoid growth frequency was
quantified after 10 days.
Statistical analysis. Single comparisons were performed using two-tailed Stu-
dent’s t-test and multiple comparisons by one-way ANOVA followed by post hoc
all pairwise multiple comparisons (Holm–Sidak). For survival analysis, Kaplan–
Meier log-rank analysis (right-censored) was performed.
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